Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$596.92 USD
+3.13 (0.53%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $596.52 -0.40 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Zacks News
Pacific Biosciences' Sequel Sees Solid Q2, Competition Rife
by Zacks Equity Research
Pacific Biosciences (PACB) gains from solid presence in Asia; competition likely to mar results.
Allscripts (MDRX) Q2 Earnings In Line, Revenues Top Estimates
by Zacks Equity Research
Allscripts (MDRX) gains from solid segmental performance in Q2; a decline in bookings discourages.
Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM
by Zacks Equity Research
Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM
CONMED (CNMD) Beats on Q2 Earnings, Raises 2018 Guidance
by Zacks Equity Research
CONMED (CNMD) sees solid domestic and international sales in Q2; raised guidance encourages.
Masimo (MASI) Beats on Q2 Earnings, Raises 2018 Guidance
by Zacks Equity Research
Masimo (MASI) gains from solid segmental performance in Q2; non-invasive technology continues to be in demand.
Becton, Dickinson (BDX) Earnings and Revenues Beat in Q3
by Zacks Equity Research
Becton, Dickinson (BDX) gains from solid segmental and geographical sales in Q3.
5 Cheap PEG Stocks Suitable for GARP Investors
by Zacks Equity Research
Although PEG is categorized under value investing, this strategy follows the principles of both growth and value investing.
The Zacks Analyst Blog Highlights: Amazon, Facebook, Thermo Fisher, Home Depot and Progressive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Facebook, Thermo Fisher, Home Depot and Progressive
Top Stock Reports for Amazon, Facebook & Thermo Fisher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Facebook (FB) and Thermo Fisher (TMO).
Thermo Fisher (TMO) Beats on Q2 Earnings, Ups '18 EPS View
by Zacks Equity Research
Thermo Fisher (TMO) is performing well on the back of a series of product launches along with major progress in precision medicine initiatives.
Thermo Fisher Scientific (TMO) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 4.56% and 2.75%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher (TMO) Beats on Q2 Earnings & Sales Estimates
by Urmimala Biswas
Thermo Fisher (TMO) has launched innovative new products in the key technology platforms and also registered strong growth in Asia-Pacific and emerging markets, including China.
Medical Product Earnings Lineup for Jul 25: TMO, BSX & More
by Zacks Equity Research
The Medical product market further gains momentum on the back of a recent two-year suspension of the controversial 2.3% Medical Device tax.
Thermo Fisher (TMO) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Thermo Fisher (TMO) continues with its impressive performance momentum across analytical instrument businesses witnessing escalating global demand.
Roper Technologies (ROP) to Divest Gatan Business for $925M
by Zacks Equity Research
Roper Technologies (ROP) agrees to divest its Pleasanton, CA-based Gatan business to Thermo Fisher Scientific (TMO), against roughly $925 million cash.
Thermo Fisher to Buy Gatan, Boost Electron Microscopy Suite
by Zacks Equity Research
Thermo Fisher (TMO) forges ahead with initiatives to strengthen foothold in the high-potential electron microscopy market.
Genomics Market Gains Momentum: 3 DNA Stocks in Focus
by Nabaparna Bhattacharya
Here we discuss about how Genomics creates opportunities in MedTech for investors who are keen on putting money in the healthcare space.
Top Research Reports for UnitedHealth, Walmart & AT&T
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Walmart (WMT) and AT&T (T).
Pacific Biosciences to Gain From New Genome Sequencing Tools
by Zacks Equity Research
Pacific Biosciences' (PACB) new multiplexing kit to make genome sequencing faster and cost-effective.
Bio-Rad Banks on Solid Global Scenario, Competition Rife
by Zacks Equity Research
Bio-Rad (BIO) delivers robust performance, primarily in North America, China and the Asia-Pacific region.
LabCorp, Unilabs Tie Up to Expand in Companion Diagnostics
by Zacks Equity Research
LabCorp (LH) continues to strengthen hold in the diagnostics space through inorganic means.
LabCorp Extends Aetna Agreement, Expands Diagnostics Business
by Zacks Equity Research
The expanded agreement enables LabCorp (LH) to serve as a preferred national laboratory to almost all of Aetna's members starting Jan 1, 2019.
LabCorp Extends UnitedHealthcare Pact, Lifts Diagnostics Arm
by Zacks Equity Research
LabCorp (LH) and UnitedHealthcare stretch links to collaborate on a variety of value-based programs.
Thermo Fisher (TMO) Gains on Latest Buyouts Despite Cost Woes
by Zacks Equity Research
Successive product launches and a marked progress in precision medicine initiatives boost Thermo Fisher's (TMO) performance.
Top Analyst Reports for Microsoft, Facebook, Intel & Boeing
by Zacks Equity Research
Today's Research Daily features new research reports on 17 major stocks, including Microsoft (MSFT), Facebook (FB), Intel (INTC) and Boeing (BA).